← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:1376 | 1376 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1376 | 1376 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1376 | 1376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-206 | 70713-206-05 | Phentolamine Mesylate; Papaverine Hydrochloride; Atropine | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1376 | 1376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-808 | 70004-808-40 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1376 | 1376 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1376 | 1376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-252 | 70324-252-01 | Phenylephrine | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1376 | 1376 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sodium Tetradecyl Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1376 | 1376 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1376 | 1376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-130 | 73198-130-30 | Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1376 | 1376 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1376 | 1376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-001 | 72055-001-01 | Succinylcholine Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1376 | 1376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5367 | 72934-5367-2 | Tacrolimus; Niacinamide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1376 | 1376 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sugammadex Sodium | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1376 | 1376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-384 | 73693-384-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1376 | 1376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2100 | 72627-2100-3 | Testosterone Cypionate | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1377 | 1377 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2425 | 72627-2425-1 | Taurine | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1377 | 1377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-9001 | 26436-9001-2 | Hydromorphone Hydrochloride | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1377 | 1377 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1377 | 1377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-218 | 70713-218-06 | Phentolamine Mesylate; Papaverine Hydrochloride; Atropine | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1377 | 1377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-810 | 70004-810-12 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1377 | 1377 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1377 | 1377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-901 | 70324-901-01 | Phenylephrine | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1377 | 1377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-116 | 73177-116-03 | Succinylcholine Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1377 | 1377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-950 | 71170-950-25 | Ropivacaine Hydrochloride; Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1377 | 1377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8721 | 72682-8721-3 | Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1377 | 1377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5056 | 26436-5056-3 | Riboflavin 5'-Phosphate Sodium | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1377 | 1377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-7536 | 60652-7536-1 | Succinylcholine Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1377 | 1377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2366 | 72934-2366-2 | Tacrolimus; Niacinamide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1377 | 1377 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sugammadex Sodium | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1377 | 1377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-381 | 73693-381-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1377 | 1377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2100 | 72627-2100-7 | Testosterone Cypionate | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1378 | 1378 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4605 | 72934-4605-8 | Holizar | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1378 | 1378 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1378 | 1378 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1378 | 1378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-218 | 70713-218-05 | Phentolamine Mesylate; Papaverine Hydrochloride; Atropine | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1378 | 1378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-810 | 70004-810-11 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1378 | 1378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2503 | 72627-2503-3 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1378 | 1378 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1378 | 1378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-116 | 73177-116-02 | Succinylcholine Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1378 | 1378 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1378 | 1378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-063 | 73198-063-30 | Pyridoxine; Niacinamide; Riboflavin; Dexpanthenol; Thiamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1378 | 1378 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Riboflavin 5'-Phosphate Sodium; Ascorbic Acid; Magnesium Chloride; Dexpanthenol; Niacinamide; Calcium Gluconate; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1378 | 1378 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1378 | 1378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5613 | 26436-5613-1 | Tadalafil | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1378 | 1378 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sugammadex Sodium | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1378 | 1378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0124 | 70168-0124-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1378 | 1378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 54288-861 | 54288-861-10 | Testosterone Cypionate | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1379 | 1379 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-375 | 73693-375-01 | ESTRADIOL 6MG | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1379 | 1379 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1379 | 1379 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1379 | 1379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-200 | 70713-200-05 | Phenylephrine | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1379 | 1379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-810 | 70004-810-22 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1379 | 1379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2504 | 72627-2504-3 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1379 | 1379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6058 | 72196-6058-1 | Phenylephrine Hydrochloride | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1379 | 1379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-629 | 68985-629-91 | Succinylcholine Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1379 | 1379 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1379 | 1379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5118 | 26436-5118-1 | Riboflavin 5'-Phosphate Sodium; Niacinamide; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1379 | 1379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5118 | 26436-5118-1 | Riboflavin 5'-Phosphate Sodium; Niacinamide; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1379 | 1379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-087 | 70092-087-46 | Succinylcholine Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1379 | 1379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0059 | 26436-0059-2 | Tadalafil | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1379 | 1379 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sugammadex Sodium | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1379 | 1379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5356 | 26436-5356-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1379 | 1379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8320 | 72682-8320-1 | Testosterone Cypionate | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1380 | 1380 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1036 | 73013-1036-1 | Morphine Sulfate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1380 | 1380 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1380 | 1380 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1380 | 1380 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1380 | 1380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-955 | 69374-955-10 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1380 | 1380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-018 | 79926-018-06 | Pentosan Polysulfate Sodium | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1380 | 1380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-811 | 70004-811-12 | Phenylephrine Hydrochloride | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1380 | 1380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-629 | 68985-629-95 | Succinylcholine Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1380 | 1380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-519 | 69374-519-50 | Ropivacaine Hydrochloride; Ketamine; Ketorolac Tromethamine | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1380 | 1380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5471 | 26436-5471-3 | Riboflavin 5'-Phosphate Sodium; Niacinamide; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1380 | 1380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5471 | 26436-5471-3 | Riboflavin 5'-Phosphate Sodium; Niacinamide; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1380 | 1380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-020 | 71170-020-05 | Succinylcholine Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1380 | 1380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5024 | 26436-5024-3 | Taurine | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1380 | 1380 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sugammadex Sodium | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1380 | 1380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8587 | 72682-8587-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1380 | 1380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-9176 | 72682-9176-1 | Testosterone Cypionate | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1381 | 1381 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-522 | 70092-522-35 | Morphine PF 1 mg/ml in 50 ml NS IVB | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1381 | 1381 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1381 | 1381 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1381 | 1381 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1381 | 1381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-305 | 69374-305-10 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1381 | 1381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-882 | 72833-882-15 | Perflubron | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1381 | 1381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-811 | 70004-811-40 | Phenylephrine Hydrochloride | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1381 | 1381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-087 | 70092-087-46 | Succinylcholine Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1381 | 1381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-515 | 69374-515-50 | Ropivacaine Hydrochloride; Ketorolac Tromethamine; Clonidine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1381 | 1381 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Niacinamide; Dexpanthenol; Pyridoxine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1381 | 1381 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Niacinamide; Dexpanthenol; Pyridoxine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1381 | 1381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-086 | 70092-086-44 | Succinylcholine Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1381 | 1381 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Taurine | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1381 | 1381 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sugammadex Sodium | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1381 | 1381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8510 | 72682-8510-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1381 | 1381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8742 | 72682-8742-1 | Testosterone Cypionate | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1382 | 1382 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0206 | 72196-0206-1 | Induction 4 to1 High K (48 meq) in RL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1382 | 1382 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1382 | 1382 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1382 | 1382 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1382 | 1382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-805 | 70004-805-40 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1382 | 1382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6509 | 71266-6509-1 | Phenol | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1382 | 1382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-805 | 70004-805-40 | Phenylephrine Hydrochloride | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1382 | 1382 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1382 | 1382 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine; Epinephrine; Clonidine; Ketorolac | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1382 | 1382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-088 | 73198-088-10 | Riboflavin; Ascorbic Acid; Magnesium Chloride; Dexpanthenol; Niacinamide; Hydroxocobalamin; Calcium Gluconate; Pyridoxine; Thiamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1382 | 1382 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Riboflavin; Niacinamide; Dexpanthenol; Pyridoxine; Thiamine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1382 | 1382 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1382 | 1382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2317 | 72934-2317-2 | Tazarotene; Niacinamide | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1382 | 1382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2554 | 72934-2554-2 | Sulfacetamide Sodium; Niacinamide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1382 | 1382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8520 | 72682-8520-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1382 | 1382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1229 | 73271-1229-1 | Testosterone Cypionate; Testosterone Propionate | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1383 | 1383 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1007 | 73013-1007-1 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1383 | 1383 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1383 | 1383 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1383 | 1383 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1383 | 1383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0104 | 60652-0104-1 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1383 | 1383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1211 | 5446-1211-03 | Phenol | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1383 | 1383 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1383 | 1383 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1383 | 1383 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine; Epinephrine; Clonidine; Ketorolac | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1383 | 1383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-2230 | 72682-2230-3 | Riboflavin; Niacinamide; Dexpanthenol; Pyridoxine; Thiamine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1383 | 1383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-129 | 73702-129-15 | Rocuronium | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1383 | 1383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-034 | 71506-034-05 | Succinylcholine Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1383 | 1383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0124 | 70168-0124-1 | Testosterone | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1383 | 1383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-3570 | 72934-3570-2 | Sulfacetamide Sodium; Niacinamide | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1383 | 1383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0011 | 70168-0011-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1383 | 1383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-043 | 70713-043-01 | Testosterone; Anastrozole | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1384 | 1384 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7022 | 71285-7022-1 | Heparin 4000units added to NS | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1384 | 1384 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1384 | 1384 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1384 | 1384 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1384 | 1384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-811 | 70004-811-12 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1384 | 1384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1476 | 5446-1476-01 | Phenol | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1384 | 1384 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1384 | 1384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-504 | 65302-504-05 | Succinylcholine Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1384 | 1384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69389-064 | 69389-064-27 | Sarracenia Purpurea | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1384 | 1384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-129 | 73702-129-15 | Rocuronium | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1384 | 1384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2002 | 71266-2002-9 | Rocuronium Bromide | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1384 | 1384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-116 | 73177-116-03 | Succinylcholine Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1384 | 1384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0080 | 70168-0080-1 | Testosterone | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1384 | 1384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4603 | 72934-4603-8 | Tacrolimus | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1384 | 1384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-1018 | 79559-1018-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1384 | 1384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-034 | 70713-034-01 | Testosterone; Anastrozole | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1385 | 1385 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2427 | 72627-2427-1 | Thiamine HCl/Riboflavin-5 Phosphate Sodium/Niacinamide/Dexpanthenol/Pyridoxine HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1385 | 1385 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1385 | 1385 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1385 | 1385 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1385 | 1385 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1385 | 1385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5412 | 26436-5412-1 | Phentermine Hydrochloride | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1385 | 1385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-807 | 70004-807-40 | Phenylephrine Hydrochloride | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1385 | 1385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-504 | 65302-504-10 | Succinylcholine Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1385 | 1385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0432 | 71285-0432-1 | Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1385 | 1385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-129 | 73702-129-10 | Rocuronium | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1385 | 1385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6010 | 71286-6010-1 | Rocuronium Bromide | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1385 | 1385 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1385 | 1385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8087 | 72682-8087-1 | Testosterone | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1385 | 1385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2540 | 72934-2540-2 | Tacrolimus | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1385 | 1385 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Testosterone | 2025-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2026-1:1385 | 1385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-014 | 70713-014-01 | Testosterone; Anastrozole | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1386 | 1386 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-418 | 70092-418-36 | Midazolam PF 1 mg/ml in 100ml NS IVB | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1386 | 1386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1386 | 1386 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1386 | 1386 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1386 | 1386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6350 | 71266-6350-1 | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1386 | 1386 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1386 | 1386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-506 | 65302-506-10 | Phenylephrine Hydrochloride | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1386 | 1386 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1386 | 1386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0418 | 72196-0418-1 | Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1386 | 1386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6010 | 72196-6010-1 | Rocuronium Bromide | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1386 | 1386 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1386 | 1386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-126 | 71449-126-15 | Succinylcholine Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1386 | 1386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8200 | 72682-8200-1 | Testosterone | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1386 | 1386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73217-002 | 73217-002-15 | Tacrolimus | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1386 | 1386 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Testosterone | 2025-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2026-1:1386 | 1386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-4104 | 79559-4104-1 | Testosterone; Anastrozole | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1387 | 1387 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0041 | 81483-0041-5 | Avastin | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1387 | 1387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-1020 | 71283-1020-1 | Hydromorphone Hydrochloride | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1387 | 1387 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1387 | 1387 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1387 | 1387 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1387 | 1387 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1387 | 1387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-810 | 70004-810-11 | Phenylephrine Hydrochloride | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1387 | 1387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-300 | 69374-300-10 | Succinylcholine Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1387 | 1387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2315 | 72627-2315-1 | Sermorelin Acetate | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1387 | 1387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2002 | 71266-2002-1 | Rocuronium Bromide | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1387 | 1387 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1387 | 1387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-629 | 68985-629-91 | Succinylcholine Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1387 | 1387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8037 | 72682-8037-1 | Testosterone | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1387 | 1387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73217-002 | 73217-002-10 | Tacrolimus | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1387 | 1387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-8105 | 70168-8105-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1387 | 1387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-4079 | 79559-4079-1 | Testosterone; Anastrozole | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1388 | 1388 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1081 | 73013-1081-1 | Fentanyl Citrate (200mcg)- Bupivacaine HCl (0.1%) | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1388 | 1388 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1388 | 1388 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1388 | 1388 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1110 | 5446-1110-01 | Phenylephrine Hydrochloride | 2020-1 | valid | 0 | 2026-10-21 | |
outsourcing:2020-2:1388 | 1388 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Tropicamide | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1388 | 1388 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1388 | 1388 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-810 | 70004-810-12 | Phenylephrine Hydrochloride | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1388 | 1388 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6011 | 71286-6011-2 | Succinylcholine Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1388 | 1388 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2314 | 72627-2314-1 | Sermorelin Acetate | 2022-2 | valid | 0 | 2026-10-21 |